Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1812)
All Articles published online
|
Feb 14, 2008 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Kim HW, Kim GH, Cheong JY, Yang US, Park SK, Song CS, Kang DH, Song GA. |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i6/908.htm |
| Number | Citing Articles |
| 1 |
Triple Therapy with Ecabet Sodium, Amoxicillin and Lansoprazole for 2 Weeks as the Rescue Regimen for H. pylori Infection. Internal Medicine 2011; 50(5): 369 doi: 10.2169/internalmedicine.50.4305
|
| 2 |
Masumi Okuda, Noriyasu Yamamoto, Nobuhisa Fukuda, Kohei Maekawa, Takeshi Kusaka, Manabu Hashimoto, Junichiro Kotake, Hiromasa Koizuka, Yoshihiro Fukuda. Effect of ecabet sodium treatment on urea breath test and stool antigen tests in volunteers with Helicobacter pylori infection. Journal of Gastroenterology and Hepatology 2012; 27(s3): 100 doi: 10.1111/j.1440-1746.2012.07080.x
|
| 3 |
Naoki Chiba. Evidence‐Based Gastroenterology and Hepatology. 2010; : 102 doi: 10.1002/9781444314403.ch6
|
| 4 |
Jie Liang, Jun Li, Ying Han, Jielai Xia, Yunsheng Yang, Wen Li, Shutian Zhang, Yongdong Wu, Yaozong Yuan, Zhaoshen Li, Yiqi Du, Minhu Chen, Baili Chen, Bo Jiang, Yang Bai, Qinsheng Wen, Kaichun Wu, Daiming Fan. Helicobacter pylori Eradication with Ecabet Sodium, Omeprazole, Amoxicillin, and Clarithromycin Versus Bismuth, Omeprazole, Amoxicillin, and Clarithromycin Quadruple Therapy: A Randomized, Open‐Label, Phase IV Trial. Helicobacter 2012; 17(6): 458 doi: 10.1111/j.1523-5378.2012.00971.x
|
| 5 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 261 doi: 10.7704/kjhugr.2020.0045
|
| 6 |
Seung Joo Kang, Hye-Kyung Jung, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2021; 21(1): 35 doi: 10.7704/kjhugr.2020.0056
|
| 7 |
Ju-Young Kim, Hyun-Ju Bae, Jungsub Choi, Jong-Rae Lim, Sang-Wook Kim, Sung-Hoon Lee, Eun-Seok Park. Efficacy of gastro-retentive forms of ecabet sodium in the treatment of gastric ulcer in rats. Archives of Pharmacal Research 2014; 37(8): 1053 doi: 10.1007/s12272-013-0278-0
|
| 8 |
Eun Jeong Gong, Sung-Cheol Yun, Hwoon-Yong Jung, Hyun Lim, Kwi-Sook Choi, Ji Yong Ahn, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Jin-Ho Kim. Meta-Analysis of First-Line Triple Therapy forHelicobacter pyloriEradication in Korea: Is It Time to Change?. Journal of Korean Medical Science 2014; 29(5): 704 doi: 10.3346/jkms.2014.29.5.704
|
| 9 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Medicine 2021; 96(3): 160 doi: 10.3904/kjm.2021.96.3.160
|
| 10 |
Joonhwan Kim, Kyungwon Kim, Jun Soo Lee, Su Young Kim, Kyung Oh Kim, Yoon Jae Kim, Kwang an Kwon, Dong Kyun Park, Jun-Won Chung. The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen. The Korean Journal of Gastroenterology 2018; 71(4): 204 doi: 10.4166/kjg.2018.71.4.204
|
| 11 |
W. Koizumi, S. Tanabe, K. Nakatani, K. Ishido, K. Nishimura, M. Azuma, T. Ae, T. Sasaki, K. Higuchi, C. Katada, N. Nakayama, K. Saigenji. Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study). Journal of Clinical Pharmacy and Therapeutics 2009; 35(3): 303 doi: 10.1111/j.1365-2710.2009.01092.x
|
| 12 |
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network meta‐analysis. Helicobacter 2017; 22(4) doi: 10.1111/hel.12389
|
| 13 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. The Korean Journal of Internal Medicine 2021; 36(4): 807 doi: 10.3904/kjim.2020.701
|
| 14 |
D. Y. Graham, L. A. Fischbach. Letter: the ethics of using inferior regimens in H. pylori randomised trials. Alimentary Pharmacology & Therapeutics 2012; 35(7): 852 doi: 10.1111/j.1365-2036.2011.04944.x
|
| 15 |
Corrado Blandizzi, Carmelo Scarpignato. A worldwide yearly survey of new data in adverse drug reactions and interactions. Side Effects of Drugs Annual 2014; 35: 633 doi: 10.1016/B978-0-444-62635-6.00036-X
|
| 16 |
Chan Hyuk Park. The first-line regimens of Helicobacter pylori eradication in Korea. Hanyang Medical Reviews 2017; 37(1): 2 doi: 10.7599/hmr.2017.37.1.2
|
| 17 |
Youhua Wang, Ben Wang, Zhi Fa Lv, Yang Yang, Fucai Wang, Hui Wang, Shuping Chen, Yong Xie, Xiaojiang Zhou. Efficacy and Safety of Ecabet Sodium as an Adjuvant Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis. Helicobacter 2014; 19(5): 372 doi: 10.1111/hel.12136
|
| 18 |
Seol So, Ji Yong Ahn, Hee Kyong Na, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon-Yong Jung. Efficacy of Ecabet Sodium for Helicobacter pylori Eradication with Sequential Therapy. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(3): 180 doi: 10.7704/kjhugr.2018.18.3.180
|
| 19 |
Gyo Hui Kim, Jin Ah Kim, Ui Won Ko, Jong Ho Park, Jue Yong Lee, Su Sin Jin, Yeon-Ho Joo, Jae Uk Shin. Eradication Rates of First-line and Second-line Therapy forHelicobacter pyloriInfection in Gyeongnam Province. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(3): 160 doi: 10.7704/kjhugr.2015.15.3.160
|
| 20 |
|
| 21 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of <i>Helicobacter pylori</i> Infection in Korea 2020. Gut and Liver 2021; 15(2): 168 doi: 10.5009/gnl20288
|